Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin

Cancer Letters

Volumn 224, Issue 2, 2005, Pages 221-228

  Duncan, Robin E ^a   El Sohemy, Ahmed ^a   Archer, Michael C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Docosahexaenoic acid; Eicosapentaenoic acids; Genistein; HMG CoA reductase; Mevastatin

Indexed keywords

COMPACTIN; DOCOSAHEXAENOIC ACID; GENISTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ICOSAPENTAENOIC ACID; ISOFLAVONE; OXIDOREDUCTASE;

ARTICLE; CELL STRAIN MCF 7; COMPETITIVE INHIBITION; CONTROLLED STUDY; DIET; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANTICARCINOGENIC AGENTS; ANTICHOLESTEREMIC AGENTS; BREAST NEOPLASMS; DIET; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; GENISTEIN; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; RNA PROCESSING, POST-TRANSCRIPTIONAL; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 19444386634     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.11.031     Document Type: Article

References (45)

1. T.J. Key, P.K. Verkasalo, and E. Banks Epidemiology of breast cancer Lancet Oncol. 2 2001 133 140
2. M.S. Morton, O. Arisaka, N. Miyake, L.D. Morgan, and B.A. Evans Phytoestrogen concentrations in serum from Japanese men and women over forty years of age J. Nutr. 132 2002 3168 3171
3. K.D. Setchell, and S.J. Cole Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling J. Agric. Food Chem. 51 2003 4146 4155
4. Y. Ito, H. Shimizu, T. Yoshimura, R.K. Ross, M. Kabuto, and N. Takatsuka Serum concentrations of carotenoids, alpha-tocopherol, fatty acids, and lipid peroxides among Japanese in Japan, and Japanese and Caucasians in the U.S. Int. J. Vitam. Nutr. Res. 69 1999 385 395
5. V. Cappelletti, L. Fioravanti, P. Miodini, and G. Di Fronzo Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle J. Cell. Biochem. 79 2000 594 600
6. K. Dampier, E.A. Hudson, L.M. Howells, M.M. Manson, R.A. Walker, and A. Gescher Differences between human breast cell lines in susceptibility towards growth inhibition by genistein Br. J. Cancer 85 2001 618 624
7. D. Han, H. Tachibana, and K. Yamada Inhibition of environmental estrogen-induced proliferation of human breast carcinoma MCF-7 cells by flavonoids In Vitro Cell. Dev. Biol. Anim. 37 2001 275 282
8. R.C. Santell, N. Kieu, and W.G. Helferich Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice J. Nutr. 130 2000 1665 1669
9. V. Tanos, A. Brzezinski, O. Drize, N. Strauss, and T. Peretz Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro Eur. J. Obstet. Gynecol. Reprod. Biol. 102 2002 188 194
10. A.I. Constantinou, A.E. Krygier, and R.R. Mehta Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice Am. J. Clin. Nutr. 68 1998 1426S 1430S
11. Z. Jin, and R.S. MacDonald Soy isoflavones increase latency of spontaneous mammary tumors in mice J. Nutr. 132 2002 3186 3190
12. A. Murkies, F.S. Dalais, E.M. Briganti, H.G. Burger, D.L. Healy, M.L. Wahlqvist, and S.R. Davis Phytoestrogens and breast cancer in postmenopausal women: a case control study Menopause 7 2000 289 296
13. S. Yamamoto, T. Sobue, M. Kobayashi, S. Sasaki, and S. Tsugane Soy, isoflavones, and breast cancer risk in Japan J. Natl Cancer Inst. 95 2003 906 913
14. W. Zheng, Q. Dai, L.J. Custer, X.O. Shu, W.Q. Wen, F. Jin, and A.A. Franke Urinary excretion of isoflavonoids and the risk of breast cancer Cancer Epidemiol. Biomarkers Prev. 8 1999 35 40
15. S.I. Grammatikos, P.V. Subbaiah, T.A. Victor, and W.M. Miller N-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines Br. J. Cancer 70 1994 219 227
16. M. Noguchi, M. Earashi, M. Minami, K. Konoshita, and I Miyazaki Effects of eicosapentaenoic and docosahexaenoic acid on cell growth and prostaglandin E and leukotriene B production by a human breast cancer cell line (MDA-MB-231) Oncology 52 1995 458 464
17. D.P. Rose, J.M. Connolly, J. Rayburn, and M. Coleman Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice J. Natl Cancer Inst. 87 1995 587 592
18. L. Kaizer, N.F. Boyd, V. Kriukov, and D. Trichler Fish consumption and breast cancer risk: an ecological study Nutr. Cancer 12 1989 61 68
19. V. Maillard, P. Bougnoux, P. Ferrari, M.L. Jourdan, M. Pinault, and F. Lavillonniere N-3 and n-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France Int. J. Cancer 98 2002 78 83
20. J. Shannon, L.S. Cook, and J.L. Stanford Dietary intake and risk of postmenopausal breast cancer (United States) Cancer Causes Control 14 2003 19 27
21. J.L. Goldstein, and M.S. Brown Regulation of the mevalonate pathway Nature 343 1990 425 430
22. M.H. Gelb Protein prenylation, et cetera: signal transduction in two dimensions Science 275 1997 1750 1751
23. K. Keyomarsi, L. Sandoval, V. Band, and A.B. Pardee Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin Cancer Res. 51 1991 3602 3609
24. D.F. Alonso, H.G. Farina, G. Skilton, M.R. Gabri, M.S. de Lorenzo, and D.E. Gomez Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis Breast Cancer Res. Treat. 50 1998 83 93
25. H. Inano, K. Suzuki, M. Onoda, and K. Wakabayashi Anti-carcinogenic activity of simvastatin during the promotion phase of radiation-induced mammary tumorigenesis of rats Carcinogenesis 18 1997 1723 1727
26. D.M. Boudreau, J.S. Gardner, K.E. Malone, S.R. Heckbert, D.K. Blough, and J.R. Daling The association between 3-hydroxy-3-methylglutaryl coenzyme a inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study Cancer 100 2004 2308 2316
27. L. Blais, A. Desgagne, and J. LeLorier 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the risk of cancer: a nested case-control study Arch. Intern. Med. 160 2000 2363 2368
28. J.A. Cauley, J.M. Zmuda, L.Y. Lui, T.A. Hillier, R.B. Ness, and K.L. Stone Lipid-lowering drug use and breast cancer in older women: a prospective study J. Women's Health 12 2003 749 756
29. P. Beck, D. Wysowski, W. Downey, and D. Butler-Jones Statin use and the risk of breast cancer J. Clin. Epidemiol. 56 2003 280 285
30. P.F. Coogan, L. Rosenberg, J.R. Palmer, B.L. Strom, A.G. Zauber, and S. Shapiro Statin use and the risk of breast and prostate cancer Epidemiology 13 2002 262 267
31. J.A. Kaye, C.R. Meier, A.M. Walker, and H. Jick Statin use, hyperlipidaemia, and the risk of breast cancer Br. J. Cancer 86 2002 1436 1439
32. R.E. Duncan, A. El-Sohemy, and M.C. Archer Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced CDK-2 activity J. Biol. Chem. 279 2004 33079 33084
33. A. El-Sohemy, and M.C. Archer Regulation of mevalonate synthesis in rat mammary glands by dietary n-3 and n-6 polyunsaturated fatty acids Cancer Res. 57 1997 3685 3687
34. N.M. Borradaile, L.E. de Dreu, L.J. Wilcox, J.Y. Edwards, and M.W. Huff Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms Biochem. J. 366 2002 531 539
35. J.H. Sung, S.J. Lee, K.H. Park, and T.W. Moon Isoflavones inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase in vitro Biosci. Biotechnol. Biochem. 68 2004 428 432
36. H. Seeger, D. Wallwiener, and A.O. Mueck Statins can inhibit proliferation of human breast cancer cells in vitro Exp. Clin. Endocrinol. Diabetes 111 2003 47 48
37. K.K.W. Chan, A.M. Oza, and L.L. Siu The statins as anticancer agents Clin. Cancer Res. 9 2003 10 19
38. L. Overbergh, A. Giulietti, D. Valckx, R. Decallonne, R. Bouillon, and C. Mathieu The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression J. Biomol. Tech. 14 2003 33 43
39. Applied Biosystems Relative quantitation of gene expression: ABI PRISM 7700 sequence detection system User Bull. 2 1997 1 36
40. A. El-Sohemy, and M.C. Archer Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations Carcinogenesis 21 2000 827 831
41. H.J. Harwood Jr., I.M. Alvarez, W.D. Noyes, and P.W. Stacpoole In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma J. Lipid Res. 32 1991 1237 1252
42. S. Kawata, K. Takaishi, T. Nagase, N. Ito, Y. Matsuda, and S. Tamura Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis Cancer Res. 50 1990 3270 3273
43. K. Kuriki, T. Nagaya, Y. Tokudome, N. Imaeda, N. Fujiwara, J. Sato, and C. Goto Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study J. Nutr. 133 2003 3643 3650
44. L.T. Bloedon, A.R. Jeffcoat, W. Lopaczynski, M.J. Schell, T.M. Black, and K.J. Dix Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women Am. J. Clin. Nutr. 76 2002 1126 1137
45. R.A. Parker, B.C. Pearce, R.W. Clark, D.A. Gordon, and J.J. Wright Tocotrienols regulate cholesterol production in mammalian cells by post- transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase J. Biol. Chem. 268 1993 11230 11238